Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $43.39 Analyst target: $37.50 Upside: -13.57%
aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.